SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-19-008108
Filing Date
2019-02-14
Accepted
2019-02-14 16:06:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv513634_sc13ga.htm SC 13G/A 26327
  Complete submission text file 0001144204-19-008108.txt   27728
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Subject) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88549 | Film No.: 19606138
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEUROTROPE, INC. 50 PARK PLACE, SUITE 1401 NEWARK NJ 07102
Business Address
McGregor Clyde (Filed by) CIK: 0001679643 (see all company filings)

Type: SC 13G/A